Research To Practice | Oncology Videos: Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Nov 19, 2024

Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo, including the following topics:

Introduction: PI3K/AKT/PTEN Pathway and Resistance to Endocrine Therapy (0:00)
First-Line Therapy for HR-Positive Metastatic Breast Cancer (mBC) Harboring PI3K/AKT/PTEN Mutations (7:04)
Treatment Options for Recurrent mBC with PI3K/AKT/PTEN Mutations (24:11)
Beyond the Guidelines Survey (35:36)
Faculty Case Presentations (51:27)